(19)
(11) EP 1 305 299 A1

(12)

(43) Date of publication:
02.05.2003 Bulletin 2003/18

(21) Application number: 01956110.9

(22) Date of filing: 02.08.2001
(51) International Patent Classification (IPC)7C07D 257/02, C07D 255/02, A61K 31/395, A61P 35/00
(86) International application number:
PCT/US0124/282
(87) International publication number:
WO 0201/0142 (07.02.2002 Gazette 2002/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.08.2000 US 222522 P

(71) Applicant: SLIL Biomedical Corporation
Madison,Wisconsin 53711-1093 (US)

(72) Inventors:
  • FRYDMAN, Benjamin
    Madison, WI 53719 (US)
  • HESSE, Manfred
    CH-8122 Binz (CH)
  • GUGGISBERG, Armin
    CH-8952 Schlieren (CH)
  • POPAJ, Kasmin
    CH-8952 Schlieren (CH)
  • DRANDAROV, Konstantin
    CH-8004 Zurich (CH)
  • BASU, Hirak
    Madison, WI 53717 (US)
  • BHATTACHARYA, Subhra
    Madison, WI 53705 (US)
  • WANG, Yu
    Madison, WI 53719-2140 (US)

(74) Representative: Roques, Sarah Elizabeth 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) CYCLIC POLYAMINE COMPOUNDS FOR CANCER THERAPY